BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 18510311)

  • 1. Sarcoplasmic reticulum calcium ATPase is inhibited by organic vanadium coordination compounds: pyridine-2,6-dicarboxylatodioxovanadium(V), BMOV, and an amavadine analogue.
    Aureliano M; Henao F; Tiago T; Duarte RO; Moura JJ; Baruah B; Crans DC
    Inorg Chem; 2008 Jul; 47(13):5677-84. PubMed ID: 18510311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of vanadium(V)-citrate complexes with the sarcoplasmic reticulum calcium pump.
    Aureliano M; Tiago T; Gândara RM; Sousa A; Moderno A; Kaliva M; Salifoglou A; Duarte RO; Moura JJ
    J Inorg Biochem; 2005 Dec; 99(12):2355-61. PubMed ID: 16219359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aqueous chemistry of the vanadium(III) (V(III)) and the V(III)-dipicolinate systems and a comparison of the effect of three oxidation states of vanadium compounds on diabetic hyperglycemia in rats.
    Buglyó P; Crans DC; Nagy EM; Lindo RL; Yang L; Smee JJ; Jin W; Chi LH; Godzala Iii ME; Willsky GR
    Inorg Chem; 2005 Jul; 44(15):5416-27. PubMed ID: 16022540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of BMOV [bis(maltolato)oxovanadium(IV)] on biochemical and morphological alterations characteristic for streptozotocin-diabetic rat liver Golgi complexes.
    Dabroś W; Dziga D; Kordowiak AM
    Pol J Pathol; 2002; 53(4):205-13. PubMed ID: 12597338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ternary oxovanadium(IV) complexes with amino acid-Schiff base and polypyridyl derivatives: synthesis, characterization, and protein tyrosine phosphatase 1B inhibition.
    Lu L; Yue J; Yuan C; Zhu M; Han H; Liu Z; Guo M
    J Inorg Biochem; 2011 Oct; 105(10):1323-8. PubMed ID: 21864810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of protein tyrosine phosphatase 1B and alkaline phosphatase by bis(maltolato)oxovanadium (IV).
    Li M; Ding W; Baruah B; Crans DC; Wang R
    J Inorg Biochem; 2008 Oct; 102(10):1846-53. PubMed ID: 18728000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into the interactions of serum proteins with bis(maltolato)oxovanadium(IV): transport and biotransformation of insulin-enhancing vanadium pharmaceuticals.
    Liboiron BD; Thompson KH; Hanson GR; Lam E; Aebischer N; Orvig C
    J Am Chem Soc; 2005 Apr; 127(14):5104-15. PubMed ID: 15810845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcoplasmic reticulum calcium ATPase interactions with decaniobate, decavanadate, vanadate, tungstate and molybdate.
    Fraqueza G; Ohlin CA; Casey WH; Aureliano M
    J Inorg Biochem; 2012 Feb; 107(1):82-9. PubMed ID: 22178669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decavanadate, decaniobate, tungstate and molybdate interactions with sarcoplasmic reticulum Ca(2+)-ATPase: quercetin prevents cysteine oxidation by vanadate but does not reverse ATPase inhibition.
    Fraqueza G; Batista de Carvalho LA; Marques MP; Maia L; Ohlin CA; Casey WH; Aureliano M
    Dalton Trans; 2012 Nov; 41(41):12749-58. PubMed ID: 22968713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of decavanadate and insulin enhancing vanadium compounds on glucose uptake in isolated rat adipocytes.
    Pereira MJ; Carvalho E; Eriksson JW; Crans DC; Aureliano M
    J Inorg Biochem; 2009 Dec; 103(12):1687-92. PubMed ID: 19850351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme inhibition, radical scavenging, and spectroscopic studies of vanadium(IV)-hydrazide complexes.
    Ashiq U; Jamal RA; Mahroof-Tahir M; Maqsood ZT; Khan KM; Omer I; Choudhary MI
    J Enzyme Inhib Med Chem; 2009 Dec; 24(6):1336-43. PubMed ID: 19912066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of vanadium(V) by L-ascorbic acid at low and neutral pH: kinetic, mechanistic, and spectroscopic characterization.
    Wilkins PC; Johnson MD; Holder AA; Crans DC
    Inorg Chem; 2006 Feb; 45(4):1471-9. PubMed ID: 16471958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, spectroscopy, and biological properties of vanadium(IV)-hydrazide complexes.
    Ashiq U; Ara R; Mahroof-Tahir M; Maqsood ZT; Khan KM; Khan SN; Siddiqui H; Choudhary MI
    Chem Biodivers; 2008 Jan; 5(1):82-92. PubMed ID: 18205128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, characterization, and application of vanadium-salan complexes in oxygen transfer reactions.
    Adão P; Costa Pessoa J; Henriques RT; Kuznetsov ML; Avecilla F; Maurya MR; Kumar U; Correia I
    Inorg Chem; 2009 Apr; 48(8):3542-61. PubMed ID: 19290614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential.
    Thompson KH; Liboiron BD; Sun Y; Bellman KD; Setyawati IA; Patrick BO; Karunaratne V; Rawji G; Wheeler J; Sutton K; Bhanot S; Cassidy C; McNeill JH; Yuen VG; Orvig C
    J Biol Inorg Chem; 2003 Jan; 8(1-2):66-74. PubMed ID: 12459900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of anti-hyperglycemic effect amongst vanadium, molybdenum and other metal maltol complexes.
    Thompson KH; Chiles J; Yuen VG; Tse J; McNeill JH; Orvig C
    J Inorg Biochem; 2004 May; 98(5):683-90. PubMed ID: 15134913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calorimetric studies of the interaction between the insulin-enhancing drug candidate bis(maltolato)oxovanadium(IV) (BMOV) and human serum apo-transferrin.
    Bordbar AK; Creagh AL; Mohammadi F; Haynes CA; Orvig C
    J Inorg Biochem; 2009 Apr; 103(4):643-7. PubMed ID: 19056126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular determinants of sarco/endoplasmic reticulum calcium ATPase inhibition by hydroquinone-based compounds.
    Lape M; Elam C; Versluis M; Kempton R; Paula S
    Proteins; 2008 Feb; 70(3):639-49. PubMed ID: 17879345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymer-anchored peroxo compounds of vanadium(V) and molybdenum(VI): synthesis, stability, and their activities with alkaline phosphatase and catalase.
    Boruah JJ; Kalita D; Das SP; Paul S; Islam NS
    Inorg Chem; 2011 Sep; 50(17):8046-62. PubMed ID: 21786762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catalysis of oxo transfer to prochiral sulfides by oxovanadium(v) compounds that model the active center of haloperoxidases.
    Santoni G; Licini G; Rehder D
    Chemistry; 2003 Oct; 9(19):4700-8. PubMed ID: 14566876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.